New treatment of Duchenne muscular dystrophy

Italfarmaco and Medis Announce Exclusive Distribution Agreement for Givinostat in 17 Central and Eastern European Countries including the Baltic States

Givinostat has already received regulatory approval in the US and UK, with an evaluation ongoing by the European Medicines Agency (EMA).

Recognition for Excellence in the Workplace

Medis Wins the Prestigious German Economy Award 2024/25

The company Medis has been awarded the German Economy Award 2024/25 in the category "Excellent Employer".

Award for outstanding achievements in management

Artemis 2024 Award to Maja Strnad Cestar

The award is presented annually by the Association of Managers to managers in Slovenia.

Commercialization of WAYA Biotic D3 drops

New Partnership with Faes Pharma Portugal

We are proud to announce a new partnership with Faes Farma Portugal for the commercialization of WAYA Biotic D3 drops under the brand name Gut4Neo.

INTERVIEW WITH MEDIS CEO MAJA STRNAD CESTAR

We Open The Doors For New Therapies

Celebrating 35 years of innovation, growth, and patient-focused solutions in healthcare across 18 European countries.

Medis Celebrates 35th Anniversary

Founded in 1989 by pharmacist Tone Strnad, Medis has grown to become one of the largest commercialization partners for the world’s leading pharmaceutical and...